Market revenue in 2023 | USD 3.7 million |
Market revenue in 2030 | USD 10.9 million |
Growth rate | 17% (CAGR from 2023 to 2030) |
Largest segment | Product |
Fastest growing segment | Service |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Product, Service |
Key market players worldwide | AstraZeneca PLC, Caribou Biosciences Inc Ordinary Shares, Cellectis SA, CRISPR Therapeutics AG, Editas Medicine Inc, Roche Holding AG, PerkinElmer, Genscript Biotech Corp Class H, Danaher Corp, Intellia Therapeutics Inc, Lonza Group Ltd, Merck KGaA, Takara Bio Inc, Thermo Fisher Scientific Inc, Cibus Inc Ordinary Shares - Class A, Beam Therapeutics Inc, Vertex Pharmaceuticals Inc, Addgene, EGenesis, Synthego, Mammoth Biosciences, Inscripta, PLANTEDIT, Hera Biotech, Origene Technologies, Recombinetics |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to crispr and cas genes market will help companies and investors design strategic landscapes.
Product was the largest segment with a revenue share of 78.38% in 2023. Horizon Databook has segmented the Saudi Arabia crispr and cas genes market based on product, service covering the revenue growth of each sub-segment from 2018 to 2030.
Extensive research studies involving genome editing techniques can help expand the usage rate of advanced CRISPR techniques in this country. In January 2020, researchers from the King Abdullah University of Science and Technology integrated Agrobacterium VirD2 release (Cas9-VirD2) and Cas9 endonuclease, which enabled efficient Homology-directed Repair (HDR).
The Cas9-VirD2 system was validated to develop herbicide-resistant rice plants, thus improving vital characteristics of crop s. Such research studies are anticipated to increase CRISPR utilization in agriculture in the country.
The advent of CRISPR has accelerated advancements in novel, efficient, and simplistic in vivo model systems in oncology. Researchers from King Abdul-Aziz University, as per a study published in December 2019, reviewed development and application of CRISPR techniques for cancer research & therapy.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia crispr and cas genes market , including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia crispr and cas genes market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account